
AffinityAI ApS offers custom AI-designed protein binders, branded as Designerbodies™, for precision research and drug development. They leverage proprietary AI platforms, ARCANE™ and RAVEN™, to design and express high-affinity, stable proteins (Kd's in pM-nM range, Tm's 60-90°C) significantly faster (5x) than traditional methods. Their solutions provide detailed structural information on binding sites and are entirely animal-free, suitable for various expression systems. AffinityAI serves pharmaceutical companies, biotechnology firms, academic groups, and clinical labs, aiming to accelerate discovery, de-risk decisions, and boost confidence across research and clinical stages.

AffinityAI ApS offers custom AI-designed protein binders, branded as Designerbodies™, for precision research and drug development. They leverage proprietary AI platforms, ARCANE™ and RAVEN™, to design and express high-affinity, stable proteins (Kd's in pM-nM range, Tm's 60-90°C) significantly faster (5x) than traditional methods. Their solutions provide detailed structural information on binding sites and are entirely animal-free, suitable for various expression systems. AffinityAI serves pharmaceutical companies, biotechnology firms, academic groups, and clinical labs, aiming to accelerate discovery, de-risk decisions, and boost confidence across research and clinical stages.